【24h】

Factual reflections and recommendations on extracorporeal photopheresis in pediatrics

机译:关于儿科体外光血髓术的事实思考和建议

获取原文
获取原文并翻译 | 示例
           

摘要

One of the biggest challenges in evaluating available literature on extracorporeal photopheresis (ECP) practices in pediatric patients is the marked heterogeneity of approaches to the patient evaluation, procedural aspects and apheresis product analysis. These issues are most relevant in ECP management in children with graft versus host disease (GVHD) after hematopoietic stem cell transplantation. Extracorporeal photopheresis in pediatric patients is considered relatively safe with few adverse effects reported from retrospective or observational studies. Careful patient eligibility assessment for ECP procedures and close monitoring while on ECP therapy is still required by transfusion medicine and pediatric specialists. Particular attention is necessary considering the rapidly changing clinical status of children with graft versus host disease after hematopoietic stem cell transplantation, focusing on hemodynamic compromise, hematologic and metabolic disturbances. This is a review of the approaches to some of the safety issues in long-term ECP therapy in low-weight pediatric patients. (C) 2017 Elsevier Ltd. All rights reserved.
机译:在儿科患者的体外光学晶宫(ECP)实践中评估可用文献的最大挑战之一是患者评估,程序方面和采血产品分析的明显异质性。这些问题在造血干细胞移植后移植物与宿主疾病(GVHD)的儿童中的ECP管理中最相关。在回顾性或观察研究中报告的少数不良反应,儿科患者体外光学施术被认为是相对安全的。输血医学和儿科专家仍然需要对ECP程序和密切监测进行仔细患者资格评估。考虑到造血干细胞移植后患有移植物与宿主疾病的儿童的临床状况迅速变化,侧重于血液动力学折衷,血液学和代谢紊乱。这是对低重量小儿患者的长期ECP疗法中一些安全问题的方法审查。 (c)2017 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号